Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 23 Sept, 09:30 pm
Biotech Stocks and Leveraged ETFs Lead Market Declines Cue Biopharma (NASDAQ: CUE) fell sharply even after reporting positive Phase 2 CUE-221 data , showing how biotech stocks can still sell off after clinical updates. DAMD , SMST , and NVOX moved sharply because leveraged and in
Acquisition Deal: Priority Technology is being taken private by an investor group led by its Chairman and CEO for approximately $1.6 billion . Analyst Rating & Price Target: Lake Street set a price target of $8.05 , matching the acquisition price, and downgraded the stock to 'Hol
General Mills (NYSE: GIS) is set to report its Q3 2026 earnings with an anticipated 16.3% decline in EPS to $0.72 . The company's revenue forecast for the quarter is approximately $4.35 billion , a decrease from the prior year. General Mills (NYSE: GIS) , a major producer of cons
Jefferies lowered its price target for Boeing (NYSE: BA), yet still sees significant upside potential. Ongoing 737 MAX production challenges are impacting Boeing's output and stock performance. Despite headwinds, some analysts maintain a positive outlook, citing improved operatin
Alkermes plc (NASDAQ: ALKS) 's drug ALKS7290 demonstrated significant efficacy in a Phase 1b study for ADHD treatment , showing a 14- to 19-point improvement on a 54-point rating scale in just two weeks. This positive clinical trial result surpasses typical placebo improvements,
Investment firm Morgan Stanley (NYSE: MS) upgraded NNN REIT (NYSE: NNN) to Overweight, citing its durable income and strong financial health. The real estate investment trust (REIT) demonstrates robust operational stability with a 99.1% portfolio occupancy rate and 97.5% fixed-ra
Wix.com Ltd. (NASDAQ: WIX) Navigates Analyst Rating, AI Strategy, and Legal Challenges Wix.com Ltd. (NASDAQ: WIX) is a significant player in the web development industry with a market capitalization of approximately $4.14 billion. UBS maintained a " Neutral " analyst rating for W
ServiceNow (NYSE: NOW) Stock Analysis: Bullish Analyst Targets Amid Market Volatility Strong analyst confidence : Cantor Fitzgerald, Guggenheim, Morgan Stanley, and BTIG Research have issued bullish views or raised price targets for ServiceNow, supporting a positive long-term out
Investment firm Piper Sandler has lowered its price target for Colgate-Palmolive (NYSE:CL) to $95 , citing difficulties in the North America business due to soft consumer demand and increased competition. Colgate-Palmolive is responding with a strategic overhaul, focusing on prem
Analysts anticipate MillerKnoll to report $0.35 EPS and $940.93 million in revenue for Q3 2026. While the North America Contract segment shows strength, the Global Retail segment faces challenges from tariffs and rising operational costs. Future EPS growth is projected to stem fr
Microsoft (NASDAQ: MSFT) Stock Analysis: Price Target Hike Meets Strong Financials and Valuation Caution Rothschild & Co Redburn raised its price target on Microsoft (NASDAQ: MSFT) to $440 from $400 , but the target remains below the stock’s current trading price. Insti
Guggenheim reiterated a Neutral rating for Accenture plc (NYSE: ACN) , citing concerns that its stock price has outpaced actual business performance. The stock experienced a significant 4.73% decline, closing at $181.29 , following negative sell-side commentary from the analyst f
Thryv Holdings is strategically divesting its traditional print directory business for $142 million to focus on its core business automation software for small and medium-sized businesses. Chairman and CEO Walsh Joe demonstrated strong confidence in the company's future by purcha
Tempus AI (NASDAQ:TEM) experienced a significant stock rally, climbing 29% in one week, driven by positive analyst sentiment and new revenue opportunities. Goldman Sachs initiated coverage with a Neutral rating and a $75.00 price target, while technical indicators like a "triple-
Abivax SA (NASDAQ: ABVX) is scheduled to report earnings on September 21, 2026, with analysts projecting an EPS of -$0.98 and revenue of $799.17 thousand . Recent positive interaction with the FDA for its drug candidate, Obefazimod, influenced stock movement, with shares settling
Analyst raises price target for Palo Alto Networks, citing a 12.77% potential upside driven by strong market trends. Palo Alto Networks reported robust Q4 2026 results, with 34% year-over-year revenue growth and a 63% increase in Next-Generation Security Annual Recurring Revenue.
National Bank has initiated an "Outperform" rating for Banyan Gold Corp. (OTC: BYAGF) , signaling positive market expectations for the gold exploration company. The company reported strong drilling results from its AurMac Project, including high-grade gold discoveries, highlighti
CrowdStrike Holdings, Inc. (NASDAQ: CRWD) has demonstrated exceptional stock performance, nearly doubling in price this year, despite broader software spending cuts. Leading financial institutions like Morgan Stanley have raised their CRWD price targets , reflecting strong analys
Headlines provided by Investing.com